<SEC-DOCUMENT>0001607062-17-000019-index.html : 20170113 <SEC-HEADER>0001607062-17-000019.hdr.sgml : 20170113 <ACCEPTANCE-DATETIME>20170113162825 ACCESSION NUMBER: 0001607062-17-000019 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20160731 FILED AS OF DATE: 20170113 DATE AS OF CHANGE: 20170113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 17528114 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 </SEC-HEADER> <DOCUMENT> <TYPE>10-K <SEQUENCE>1 <FILENAME>gnbt073116form10k.htm <DESCRIPTION>FORM 10-K <TEXT> Document 1 - file: gnbt073116form10k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-31.1 <SEQUENCE>2 <FILENAME>ex31_1.htm <DESCRIPTION>EXHIBIT 31.1 <TEXT> Document 2 - file: ex31_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-31.2 <SEQUENCE>3 <FILENAME>ex31_2.htm <DESCRIPTION>EXHIBIT 31.2 <TEXT> Document 3 - file: ex31_2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-32 <SEQUENCE>4 <FILENAME>ex32.htm <DESCRIPTION>EXHIBIT 32 <TEXT> Document 4 - file: ex32.htm
</DOCUMENT> </SEC-DOCUMENT>